Novartis AG SEC filings NVS

Novartis AG has 1,000 filings in SEC EDGAR's recent list, going back to Apr 27, 2009. Its latest annual report, Form 20-F, was filed on Feb 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on December 31.

Novartis AG SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 27, 2026 Sep 30, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Sep 4, 2026 Sep 4, 2026
6-K Current report (foreign issuer) Sep 1, 2026 Sep 1, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
6-K Current report (foreign issuer) Apr 28, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Mar 18, 2026 Mar 18, 2026
424B5 Prospectus supplement Mar 17, 2026 —
FWP Free writing prospectus Mar 17, 2026 —
424B5 Prospectus supplement Mar 16, 2026 —
S-8 Employee stock plan registration Feb 4, 2026 —
6-K Current report (foreign issuer) Feb 4, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Feb 4, 2026 Dec 31, 2025
IRANNOTICE Filing Feb 4, 2026 —
20-F Annual report (foreign issuer) Feb 4, 2026 Dec 31, 2025
S-8 POS Filing Jan 16, 2026 —
S-8 POS Filing Jan 16, 2026 —
S-8 POS Filing Jan 16, 2026 —
S-8 POS Filing Jan 16, 2026 —
DFAN14A Filing Jan 14, 2026 —
DFAN14A Filing Jan 12, 2026 —
6-K Current report (foreign issuer) Nov 25, 2025 Nov 24, 2025
6-K Current report (foreign issuer) Nov 20, 2025 Nov 20, 2025
6-K Current report (foreign issuer) Nov 5, 2025 Nov 5, 2025
424B5 Prospectus supplement Nov 4, 2025 —
FWP Free writing prospectus Nov 4, 2025 —
424B5 Prospectus supplement Nov 3, 2025 —
DFAN14A Filing Oct 28, 2025 —
SC TO-T/A Filing Oct 28, 2025 —
DFAN14A Filing Oct 28, 2025 —
6-K Current report (foreign issuer) Oct 28, 2025 Sep 30, 2025
DFAN14A Filing Oct 27, 2025 —
DFAN14A Filing Oct 27, 2025 —
DFAN14A Filing Oct 27, 2025 —
6-K Current report (foreign issuer) Oct 27, 2025 Oct 27, 2025
SC TO-T/A Filing Oct 22, 2025 —
SC TO-T/A Filing Oct 20, 2025 —
6-K Current report (foreign issuer) Sep 30, 2025 Sep 30, 2025
SC TO-T Filing Sep 29, 2025 —
SC TO-C Filing Sep 9, 2025 —
6-K Current report (foreign issuer) Aug 11, 2025 Aug 11, 2025
6-K Current report (foreign issuer) Jul 17, 2025 Jul 17, 2025
6-K Current report (foreign issuer) Jul 17, 2025 Jun 30, 2025
SC TO-T/A Filing Jun 25, 2025 —
SC TO-T/A Filing Jun 23, 2025 —
SC TO-T/A Filing Jun 17, 2025 —
6-K Current report (foreign issuer) Jun 2, 2025 Apr 3, 2025
SC TO-T Filing May 27, 2025 —
SC TO-C Filing May 1, 2025 —
SC TO-C Filing Apr 30, 2025 —
6-K Current report (foreign issuer) Apr 29, 2025 Mar 31, 2025
UPLOAD Letter from the SEC Apr 8, 2025 —
6-K Current report (foreign issuer) Apr 3, 2025 Apr 3, 2025
CORRESP Letter to the SEC Mar 31, 2025 —
6-K Current report (foreign issuer) Mar 28, 2025 Mar 28, 2025
UPLOAD Letter from the SEC Mar 18, 2025 —
6-K Current report (foreign issuer) Jan 31, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Jan 31, 2025 Dec 31, 2024
IRANNOTICE Filing Jan 31, 2025 —
20-F Annual report (foreign issuer) Jan 31, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Dec 30, 2024 Dec 30, 2024
6-K Current report (foreign issuer) Nov 25, 2024 Nov 21, 2024
6-K Current report (foreign issuer) Oct 29, 2024 Oct 29, 2024
6-K Current report (foreign issuer) Oct 29, 2024 Sep 30, 2024
6-K Current report (foreign issuer) Sep 18, 2024 Sep 18, 2024
424B5 Prospectus supplement Sep 17, 2024 —
6-K Current report (foreign issuer) Sep 17, 2024 Sep 17, 2024
FWP Free writing prospectus Sep 16, 2024 —
424B5 Prospectus supplement Sep 16, 2024 —
F-3ASR Filing Sep 16, 2024 —
SC TO-T/A Filing Aug 13, 2024 —
6-K Current report (foreign issuer) Aug 8, 2024 Aug 7, 2024
SC TO-T/A Filing Aug 7, 2024 —
SC TO-T/A Filing Aug 2, 2024 —
SC TO-T/A Filing Aug 1, 2024 —
SC TO-T/A Filing Jul 31, 2024 —
SC TO-T/A Filing Jul 30, 2024 —
SC TO-T/A Filing Jul 29, 2024 —
SC TO-T/A Filing Jul 25, 2024 —
SC TO-T/A Filing Jul 18, 2024 —
6-K Current report (foreign issuer) Jul 18, 2024 Jun 30, 2024
SC TO-T/A Filing Jul 11, 2024 —
SC TO-T Filing Jul 5, 2024 —
SC TO-C Filing Jun 20, 2024 —
SC TO-T/A Filing Jun 4, 2024 —
SD Specialized disclosure (conflict minerals) May 31, 2024 —
SC TO-T/A Filing May 24, 2024 —
SC TO-T/A Filing May 16, 2024 —
SC TO-T/A Filing May 13, 2024 —
SC TO-T/A Filing May 10, 2024 —
SC TO-T/A Filing May 8, 2024 —
SC TO-T/A Filing May 7, 2024 —
SC TO-T/A Filing May 6, 2024 —
SC TO-T/A Filing May 2, 2024 —
SC TO-T/A Filing Apr 25, 2024 —
6-K Current report (foreign issuer) Apr 23, 2024 Mar 31, 2024
SC TO-T/A Filing Apr 18, 2024 —
SC TO-T/A Filing Apr 17, 2024 —
SC TO-T/A Filing Apr 16, 2024 —
SC TO-T/A Filing Apr 15, 2024 —
SC TO-T Filing Apr 11, 2024 —
S-8 POS Filing Feb 15, 2024 —
SC TO-C Filing Feb 6, 2024 —
SC TO-C Filing Feb 5, 2024 —
6-K Current report (foreign issuer) Jan 31, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Jan 31, 2024 Dec 31, 2023
IRANNOTICE Filing Jan 31, 2024 —
20-F Annual report (foreign issuer) Jan 31, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Jan 8, 2024 Jan 8, 2024
6-K Current report (foreign issuer) Dec 11, 2023 Dec 11, 2023
6-K Current report (foreign issuer) Dec 6, 2023 Dec 5, 2023
6-K Current report (foreign issuer) Nov 28, 2023 Nov 28, 2023
6-K Current report (foreign issuer) Oct 30, 2023 Oct 30, 2023
6-K Current report (foreign issuer) Oct 24, 2023 Sep 30, 2023
6-K Current report (foreign issuer) Oct 4, 2023 Oct 4, 2023
6-K Current report (foreign issuer) Oct 2, 2023 Oct 2, 2023
6-K Current report (foreign issuer) Sep 5, 2023 Sep 5, 2023
6-K Current report (foreign issuer) Aug 21, 2023 Aug 18, 2023
6-K Current report (foreign issuer) Aug 9, 2023 Aug 9, 2023
6-K Current report (foreign issuer) Jul 18, 2023 Jun 30, 2023
DFAN14A Filing Jul 10, 2023 —
6-K Current report (foreign issuer) Jul 10, 2023 Jul 7, 2023
DFAN14A Filing Jun 12, 2023 —
6-K Current report (foreign issuer) Jun 12, 2023 Jun 12, 2023
SD Specialized disclosure (conflict minerals) May 31, 2023 —
UPLOAD Letter from the SEC May 22, 2023 —
20-F/A Amended annual report (foreign issuer) May 15, 2023 Dec 31, 2022
CORRESP Letter to the SEC May 9, 2023 —
UPLOAD Letter from the SEC Apr 25, 2023 —
6-K Current report (foreign issuer) Apr 25, 2023 Mar 31, 2023
6-K Current report (foreign issuer) Mar 27, 2023 Mar 27, 2023
S-8 POS Filing Mar 24, 2023 —
6-K Current report (foreign issuer) Feb 1, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Feb 1, 2023 Dec 31, 2022
IRANNOTICE Filing Feb 1, 2023 —
20-F Annual report (foreign issuer) Feb 1, 2023 Dec 31, 2022
S-8 POS Filing Jan 10, 2023 —
F-6 POS Filing Dec 16, 2022 —
6-K Current report (foreign issuer) Dec 5, 2022 Dec 5, 2022
6-K Current report (foreign issuer) Oct 25, 2022 Sep 30, 2022
6-K Current report (foreign issuer) Oct 24, 2022 Oct 24, 2022
6-K Current report (foreign issuer) Sep 21, 2022 Sep 21, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Aug 25, 2022
6-K Current report (foreign issuer) Jul 19, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jun 21, 2022 Jun 21, 2022
SD Specialized disclosure (conflict minerals) May 31, 2022 —
20-F/A Amended annual report (foreign issuer) Apr 26, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Apr 26, 2022 Mar 31, 2022
6-K Current report (foreign issuer) Apr 4, 2022 Apr 4, 2022
6-K Current report (foreign issuer) Mar 24, 2022 Mar 23, 2022
IRANNOTICE Filing Feb 2, 2022 —
20-F Annual report (foreign issuer) Feb 2, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Feb 2, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Dec 22, 2021 Dec 22, 2021
6-K Current report (foreign issuer) Dec 20, 2021 Dec 20, 2021
6-K Current report (foreign issuer) Dec 17, 2021 Dec 16, 2021
6-K Current report (foreign issuer) Nov 4, 2021 Nov 4, 2021
6-K Current report (foreign issuer) Oct 26, 2021 Sep 30, 2021
6-K Current report (foreign issuer) Oct 25, 2021 Oct 25, 2021
6-K Current report (foreign issuer) Aug 3, 2021 Aug 3, 2021
S-8 Employee stock plan registration Jul 22, 2021 —
6-K Current report (foreign issuer) Jul 21, 2021 Jun 30, 2021
6-K Current report (foreign issuer) Jun 28, 2021 Jun 28, 2021
SD Specialized disclosure (conflict minerals) Jun 1, 2021 —
6-K Current report (foreign issuer) Apr 27, 2021 Mar 31, 2021
6-K Current report (foreign issuer) Mar 23, 2021 Mar 23, 2021
6-K Current report (foreign issuer) Mar 22, 2021 Mar 22, 2021
6-K Current report (foreign issuer) Mar 9, 2021 Mar 9, 2021
6-K Current report (foreign issuer) Mar 5, 2021 Mar 5, 2021
6-K Current report (foreign issuer) Feb 16, 2021 Feb 16, 2021
6-K Current report (foreign issuer) Jan 29, 2021 Jan 29, 2021
6-K Current report (foreign issuer) Jan 26, 2021 Dec 31, 2020
IRANNOTICE Filing Jan 26, 2021 —
20-F Annual report (foreign issuer) Jan 26, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Jan 22, 2021 —
CORRESP Letter to the SEC Jan 19, 2021 —
UPLOAD Letter from the SEC Dec 22, 2020 —
6-K Current report (foreign issuer) Dec 21, 2020 Dec 18, 2020
6-K Current report (foreign issuer) Nov 24, 2020 Nov 24, 2020
S-8 Employee stock plan registration Nov 19, 2020 —
6-K Current report (foreign issuer) Oct 27, 2020 Sep 30, 2020
6-K Current report (foreign issuer) Oct 16, 2020 Oct 16, 2020
6-K Current report (foreign issuer) Sep 23, 2020 Sep 23, 2020
6-K Current report (foreign issuer) Sep 1, 2020 Sep 1, 2020
6-K Current report (foreign issuer) Aug 20, 2020 Aug 20, 2020
6-K Current report (foreign issuer) Aug 17, 2020 Aug 17, 2020
6-K Current report (foreign issuer) Jul 21, 2020 Jun 30, 2020
6-K Current report (foreign issuer) Jul 2, 2020 Jul 2, 2020
6-K Current report (foreign issuer) Jun 25, 2020 Jun 25, 2020
6-K Current report (foreign issuer) Jun 17, 2020 Jun 17, 2020
SD Specialized disclosure (conflict minerals) Jun 1, 2020 —
6-K Current report (foreign issuer) May 12, 2020 May 6, 2020
S-8 POS Filing Apr 30, 2020 —
S-8 POS Filing Apr 30, 2020 —
S-8 POS Filing Apr 30, 2020 —
S-8 POS Filing Apr 30, 2020 —
6-K Current report (foreign issuer) Apr 28, 2020 Mar 31, 2020
6-K Current report (foreign issuer) Apr 2, 2020 Apr 2, 2020
6-K Current report (foreign issuer) Mar 27, 2020 Mar 27, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NVS (NYSE), NVSEF (OTC)
Fiscal year ends
December 31
Incorporated in
Switzerland
Headquarters
Basel, Switzerland
SEC filer status
Large accelerated filer
SEC CIK
1114448

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.